Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02360956
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02360956
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02360956. Randomized; single masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
- Condition
- Coronary Atherosclerosis
- Intervention (Drug)
- Olmesartan medoxomil tablets
- Intervention (Drug)
- Antihypertensive medication (per doctor suggestion)
- Lead sponsor
- Chinese PLA General Hospital
Record details
- Record id
cardio:ct-nct02360956- Content hash
26f3ad21a78d8f50dd2d802226ce53a9738ef98d61444d174b0cf29d39b4fc9a